| P – Patients undergoing induction treatment for AML |
| I – Anthracycline agent (daunorubicin, doxorubicin, idarubicin) |
| C – |
| O – Complete remission rate, overall survival, and disease-free survival |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.